Search results for "From ACP Internist Weekly"
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/12/14/9.htm
14 Dec 2018
HbA1c levels may overestimate mean glucose in black type 1 diabetes patients, study finds
Editorialists cautioned that the study does not suggest that HbA1c has limited utility in black patients, adding that there is a need to better understand the subgroups that may be vulnerable to discordant HbA1c and glucose measures.
https://diabetes.acponline.org/archives/2017/07/14/6.htm
14 Jul 2017
New guideline offers recommendations for older patients with diabetes or prediabetes
The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
https://diabetes.acponline.org/archives/2019/04/05/6.htm
5 Apr 2019
Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds
Only 3 factors were associated with greater long-term weight loss: preoperative insulin use, history of smoking, and use of 12 or more medications before surgery.
https://diabetes.acponline.org/archives/2016/09/16/6.htm
16 Sep 2016
Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients
Even near-normal glucose levels on the last day of hospitalization were associated with increased risk for readmission and postdischarge mortality, and these risks increased as patients' glucose levels decreased.
https://diabetes.acponline.org/archives/2019/05/10/12.htm
10 May 2019
ACP recommends less intensive glucose control in most cases of type 2 diabetes
The evidence-based guidance statement from ACP calls for personalized goals and an HbA1c target between 7% and 8% for most patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/03/09/6.htm
9 Mar 2018
Task Force recommends screening for type 2 diabetes in overweight, obese adults
The U.S. Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in overweight and obese adults ages 40 to 70 years.
https://diabetes.acponline.org/archives/2015/11/13/8.htm
13 Nov 2015
Lifestyle modification may outperform medications over time for diabetes prevention, meta-analysis finds
Twenty-five people would need to be treated with lifestyle modification to prevent one diabetes case, according to the analysis of randomized clinical trials that evaluated lifestyle modification and medication interventions for diabetes prevention in at-risk adults.
https://diabetes.acponline.org/archives/2017/12/08/6.htm
8 Dec 2017
Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes
Mortality risk was highest in patients who had both type 2 diabetes and ischemic heart disease and had not had previous revascularization.
https://diabetes.acponline.org/archives/2016/10/07/7.htm
7 Oct 2016
Diabetes Collaborative Registry seeks primary care participants
ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality of a practice's diabetes care for free.
https://diabetes.acponline.org/archives/2015/08/14/8.htm
14 Aug 2015